PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

ChargePoint Technology expands smart monitoring technology into North America

Powder containment and sterile transfer solutions provider, ChargePoint Technology has achieved HazLoc (Hazardous Area) certification for VERIFI to further support customers in North America

The HazLoc certification has been granted by the Canadian Standards Association (CSA) and will enable ChargePoint to expand its VERIFI smart monitoring hub into the North American market.

The VERIFI smart monitoring hub is a first-of-its-kind technology which monitors usage of ChargePoint’s split butterfly valve (SBV), used to provide containment during pharmaceutical manufacturing.

VERIFI continuously records valve-use providing data that allows production teams to manage and maintain their containment solution in a proactive and efficient manner. In turn, this helps assure operator safety and sterility assurance related performance during pharmaceutical manufacturing processes.

Chris Rombach, president at ChargePoint Technology Inc. commented: “Having seen the positive impact and excellent response to VERIFI in European markets, we are proud to bring VERIFI to North America. We can now give our customers more autonomy to improve operational performance and productivity, as well as helping them manage risk in their manufacturing processes.”

ChargePoint Technology has worked closely with CSA over the last two years to achieve the certification for Class 1 Zone 0 and Class II/III Zone 21, which was granted after an inspection of the company’s Liverpool, UK manufacturing headquarters in late 2018.

The company already holds Atmosphere Explosive (ATEX) and International Electro Commission (IEC) Explosive (Ex) certifications, allowing the use of VERIFI in hazardous environments in Europe.

Adam Bunyard, director of innovation and technology at ChargePoint Technology said: “Our customer base in the North American market is rapidly growing and we are excited to now be able to support existing and future customers with our unique smart monitoring technology.

“As the industry moves towards Industry 4.0, ChargePoint will remain at the forefront of contained transfer innovation, responding to the challenges of today and tomorrow.”

ChargePoint Technology’s solutions also include its AseptiSafe range of SBVs, designed to increase sterility assurance for ingredient and small component transfers in aseptic processing.

All of ChargePoint Technology’s transfer solutions are independently performance tested to the ISPE SMEPAC guidelines. The company works with select material handling solution partners globally to ensure an integrated high containment handling process is successfully achieved.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026